Lv7428
4408 积分 2024-09-04 加入
Towards mRNA therapeutics 2.0
1个月前
已完结
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study
1个月前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
1个月前
已完结
The evolving landscape of obesity pharmacotherapy
1个月前
已完结
An Update on Patent issues regarding Antibody Drug Conjugates
2个月前
已完结
Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-68oo, a poly(ADP- ribose) polymerase inhibitor
3个月前
已完结
A Novel Methionine-Based Signaling Mechanism Regulating the Expression of Thymidylate Synthase
3个月前
已完结
The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity
3个月前
已完结
Topoisomerase I inhibitors: Challenges, progress and the road ahead
4个月前
已完结
Topoisomerase I inhibitors: camptothecins and beyond
4个月前
已完结
皖公网安备34019202002308
